Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

Part of paid clinical trials in Dallas, Texas.

Sponsor
University of Texas Southwestern Medical Center
Study ID
NCT06400550
Status
Recruiting
Apply to this trial

Conditions

  • Melanoma (Skin)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this study is to observe metabolic features associated with human melanoma tumors.

Key Dates

Start date
Aug 1, 2018
Status verified
Jun 2026
Primary completion
Aug 1, 2028
Completion
Aug 1, 2028

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: 13C-glucose infusion
    Tumor samples of patients who receive the optional 13C-glucose infusion will be studied using flux analysis and metabolomic profiling.
  • Arm: No 13C-glucose infusion
    Tumor samples of patients who do not receive the optional 13C-glucose infusion will be studied using metabolomic profiling alone.

Primary Outcome Measure

Glucose Utilisation in the TCA cycle [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Texas Southwestern Medical CenterDallasTexas75390
Aleuna Lee
[email protected]
2146458968

Find similar trials in Dallas, TX

By research site
University of Texas Southwestern Medical Center· Dallas, TX

Related Studies